Cochlear Implant Program
Who we are
The Cochlear Implant Program at Boston Children's Hospital is an interdisciplinary program within the Department of Otolaryngology and Communication Enhancement. Our program, led by Greg Licameli, MD, FACS, is the largest and most comprehensive pediatric cochlear implant program in New England. We offer advanced technology combined with unparalleled personal care, provided by a team of highly qualified clinicians.
The ultimate goal of the Cochlear Implant Program is to give your child the tools he or she needs to understand language and learn to communicate effectively and confidently.
We pride ourselves on a comprehensive approach to care. We strive:
- to provide accurate and complete information to your family about the available options to help your child learn to communicate
- to assess your child's language skills and potential to benefit from a cochlear implant in the context of his or her general health and development, family, culture, and educational options
- to provide comprehensive evaluations, cochlear implant surgery and follow-up in a pediatric setting, supportive of the needs of your child and your family
- to provide ongoing care and professional support to your family--and to your child's educational program--following cochlear implant surgery
- to place your child's emotional well-being as an effective communicator foremost in all planning for medical and educational care
- to advance the field of knowledge about cochlear implantation and about the best ways of integrating this option into the lives of your family and child
Largest in New England
Children's offers the largest, most comprehensive pediatric cochlear implant program in New England and one of the most experienced in the country. The breadth and depth of our care have ranked us among the top two pediatric hospitals in the nation for 20 years. At Children's, we care for the whole child, not just for the ears.
The Cochlear Implant Program at Children's participates in FDA pediatric investigational trials for new cochlear implants. So far, we have participated in the FDA investigational trials for the Nucleus 24, Nucleus 24 Contour and Clarion HiFocus cochlear implants.